Загрузка...
Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
Lurasidone is a novel antipsychotic agent approved for the treatment of schizophrenia in a number of countries including the UK, and is also approved in the USA and Canada for the treatment of major depressive episodes associated with bipolar I disorder as either a monotherapy or adjunctive therapy...
Сохранить в:
| Опубликовано в: : | BJPsych Bull |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Royal College of Psychiatrists
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4706192/ https://ncbi.nlm.nih.gov/pubmed/26755968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/pb.bp.114.048793 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|